Safety and Feasibility Study of Autologous Engineered Urethral Constructs for the Treatment of Strictures

Summary

This is a Phase I clinical study to determine the safety and efficacy of using autologous, engineered urethral constructs for the treatment of urethral strictures in adult males. The proposed study design is a prospective non-randomized and uncontrolled single-center investigation. Autologous urothelial cells (UCs) and smooth muscle cells (SMCs), obtained from enrolled male subjects' bladder tissue samples, will be culture expanded in vitro and used to seed tubular PGA scaffolds to create autologous urethral constructs for the repair of urethral strictures.

Timeline

Start

2026-08

Primary completion

2028-12

Completion

2029-12

Drugs

Indications